EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dominant negative ADA2 mutations cause ADA2 deficiency in heterozygous carriers

Marjon Wouters iD, Lisa Ehlers iD, Wout Van Eynde iD, Meltem Ece Kars iD, Selket Delafontaine iD, Verena Kienapfel iD, Mariia Dzhus iD, Rik Schrijvers iD, Petra De Haes iD, Sofie Struyf iD, Giorgia Bucciol iD, Yuval Itan iD und 6 weitere

Journal of Experimental Medicine · 03.11.2025 · 222 (11)

DOI: 10.1084/jem.20250499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 27.08.2025. Verfasst von Marjon Wouters und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Laboratory Inborn Errors of Immunity, Immunology and Transplantation, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Heterozygote, Adenosine Deaminase, Severe Combined Immunodeficiency, Intercellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charité - Universitätsmedizin Berlin, Research Foundation Flanders, Berlin Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human ADA2 deficiency (DADA2) is an inborn error of immunity with a broad clinical phenotype, which encompasses vasculopathy and hemato-immunological features. Diagnosis is based on the combination of decreased serum ADA2 activity and the identification of biallelic deleterious alleles in the ADA2 gene. DADA2 carriers harbor a single pathogenic variant in ADA2 and are mostly considered healthy and asymptomatic. Here, we report ten patients from seven kindreds presenting with a phenotype indicative of DADA2, in whom only a single pathogenic variant was identified. We investigated the effect of these and additional reported ADA2 missense variants on ADA2 protein expression, secretion, and enzymatic activity. Our studies indicate that p.G47A, p.G47R, p.G47V, p.R169Q, p.E328K, p.H424N, and p.Y453C exert a dominant negative effect on ADA2 enzymatic activity, dimerization, and/or secretion. We conclude that humans with heterozygous dominant negative missense variants in ADA2 are at risk of DADA2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeterozygoteAdenosine DeaminaseSevere Combined ImmunodeficiencyIntercellular Signaling Peptides and ProteinsAgammaglobulinemiaMutationGenes, DominantHumansMaleFemaleMutation, MissensePedigreeChildChild, PreschoolPhenotypeAdultHereditary Autoinflammatory Diseases

Substanzen

ADA2 protein, humanAdenosine DeaminaseIntercellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Microbiology, Laboratory Inborn Errors of Immunity, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt- Universitat zu Berlin, Berlin, German…
  • Berlin Institute of Health at Charite - Universitatsmedizin Berlin , Berlin, Germany.
  • German Center for Child and Adolescent Health, Partner Site Berlin , Berlin, Germany.
  • Deutsches Rheuma-Forschungszentrum, an Institute of the Leibniz Association , Berlin, Germany.
  • Department of Chemistry, Biochemistry, Molecular and Structural Biology, KU Leuven, Leuven, Belgium.

ORCID-Profile: Marjon Wouters, Lisa Ehlers, Wout Van Eynde, Meltem Ece Kars, Selket Delafontaine, Verena Kienapfel, Mariia Dzhus, Rik Schrijvers, Petra De Haes, Sofie Struyf, Giorgia Bucciol, Yuval Itan, Alexandre Bolze, Arnout Voet, Anneleen Hombrouck, Leen Moens, Benson Ogunjimi, Isabelle Meyts

Förderung

  • Charité - Universitätsmedizin Berlin
  • Research Foundation Flanders
  • Berlin Institute of Health
  • KU Leuven
  • European Research Council
  • Icahn School of Medicine at Mount Sinai
  • European Reference Center for Primary Immunodeficiency Disorders, Autoinflammatory Disorders, Autoimmune Diseases and Pediatric Rheumatology
  • NCATS NIH HHS

Zitieren

APA

Wouters, M., Ehlers, L., Van Eynde, W., Kars, M. E., Delafontaine, S., Kienapfel, V., Dzhus, M., Schrijvers, R., De Haes, P., Struyf, S., Bucciol, G., Itan, Y., Bolze, A., Voet, A., Hombrouck, A., Moens, L., Ogunjimi, B., & Meyts, I. (2025). Dominant negative ADA2 mutations cause ADA2 deficiency in heterozygous carriers. Journal of Experimental Medicine, 222(11). https://doi.org/10.1084/jem.20250499

Vancouver

Wouters M, Ehlers L, Van Eynde W, Kars ME, Delafontaine S, Kienapfel V, et al. Dominant negative ADA2 mutations cause ADA2 deficiency in heterozygous carriers. Journal of Experimental Medicine. 2025;222(11). doi:10.1084/jem.20250499

BibTeX
@article{Wouters2025,
  author = {Wouters, Marjon and Ehlers, Lisa and Van Eynde, Wout and Kars, Meltem Ece and Delafontaine, Selket and Kienapfel, Verena and Dzhus, Mariia and Schrijvers, Rik and De Haes, Petra and Struyf, Sofie and Bucciol, Giorgia and Itan, Yuval and Bolze, Alexandre and Voet, Arnout and Hombrouck, Anneleen and Moens, Leen and Ogunjimi, Benson and Meyts, Isabelle},
  title = {Dominant negative ADA2 mutations cause ADA2 deficiency in heterozygous carriers},
  journal = {Journal of Experimental Medicine},
  year = {2025},
  volume = {222},
  number = {11},
  doi = {10.1084/jem.20250499}
}
Kostenlos starten →